Southernsun Asset Management Has Trimmed By $13.17 Million Its Darling Ingredients (DAR) Stake; 5 Bullish Analysts Covering Orthofix International N.V. (OFIX)

January 18, 2018 - By Nellie Frank

Among 5 analysts covering Orthofix International (NASDAQ:OFIX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Orthofix International had 9 analyst reports since August 18, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Thursday, June 29 report. Jefferies maintained the shares of OFIX in report on Monday, October 30 with “Buy” rating. The company was maintained on Sunday, September 10 by Jefferies. Gabelli maintained the stock with “Buy” rating in Wednesday, August 9 report. The rating was maintained by BTIG Research with “Buy” on Tuesday, August 8. See Orthofix International N.V. (NASDAQ:OFIX) latest ratings:

30/10/2017 Broker: Jefferies Rating: Buy New Target: $61.0 Maintain
10/09/2017 Broker: Jefferies Rating: Buy New Target: $55.0 Maintain
08/08/2017 Broker: BTIG Research Rating: Buy New Target: $54.0000 Maintain
09/08/2017 Broker: Gabelli Rating: Buy Maintain

Southernsun Asset Management Llc decreased Darling Ingredients Inc. (DAR) stake by 4.83% reported in 2017Q3 SEC filing. Southernsun Asset Management Llc sold 774,991 shares as Darling Ingredients Inc. (DAR)’s stock rose 25.73%. The Southernsun Asset Management Llc holds 15.27 million shares with $267.52M value, down from 16.04M last quarter. Darling Ingredients Inc. now has $3.08 billion valuation. The stock decreased 1.21% or $0.23 during the last trading session, reaching $18.71. About 437,663 shares traded. Darling Ingredients Inc. (NYSE:DAR) has risen 8.56% since January 18, 2017 and is uptrending. It has underperformed by 8.14% the S&P500.

Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. The company has market cap of $980.77 million. It operates through four divisions: BioStim, Biologics, Extremity Fixation, and Spine Fixation. It has a 690.38 P/E ratio. The BioStim segment makes, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures.

Since August 10, 2017, it had 0 insider buys, and 5 sales for $1.43 million activity. DOUG RICE sold $363,689 worth of Orthofix International N.V. (NASDAQ:OFIX) on Monday, September 11. On Monday, December 11 the insider NIEMANN BRADLEY V. sold $288,861. On Monday, August 21 the insider Mason Brad sold $131,457. $299,502 worth of Orthofix International N.V. (NASDAQ:OFIX) was sold by FUJIKAWA RAYMOND.

Investors sentiment increased to 1.16 in Q3 2017. Its up 0.39, from 0.77 in 2017Q2. It improved, as 7 investors sold Orthofix International N.V. shares while 48 reduced holdings. 23 funds opened positions while 41 raised stakes. 16.83 million shares or 1.08% less from 17.02 million shares in 2017Q2 were reported. Rhumbline Advisers reported 39,123 shares. Loomis Sayles Lp owns 489 shares. Swiss National Bank reported 30,900 shares stake. Geode Capital Mgmt Ltd Limited Liability Company holds 0% of its portfolio in Orthofix International N.V. (NASDAQ:OFIX) for 246,375 shares. Paradice Invest Mgmt Lc invested in 0.56% or 157,200 shares. Nationwide Fund Advsrs owns 35,593 shares. California State Teachers Retirement has invested 0% of its portfolio in Orthofix International N.V. (NASDAQ:OFIX). Blackrock Inc invested in 0.01% or 2.27M shares. Teachers Retirement Systems Of The State Of Kentucky reported 26,831 shares. Glenmede Na owns 221 shares. Barclays Public Lc accumulated 12,305 shares. Comml Bank Of New York Mellon Corp holds 216,325 shares or 0% of its portfolio. Pinebridge Ltd Partnership holds 2,255 shares. Schwab Charles Investment Mngmt holds 0% of its portfolio in Orthofix International N.V. (NASDAQ:OFIX) for 116,394 shares. Vanguard Grp Inc Inc invested in 1.61M shares or 0% of the stock.

The stock increased 1.60% or $0.85 during the last trading session, reaching $53.85. About 584,440 shares traded or 411.16% up from the average. Orthofix International N.V. (NASDAQ:OFIX) has declined 3.00% since January 18, 2017 and is downtrending. It has underperformed by 19.70% the S&P500.

Analysts await Darling Ingredients Inc. (NYSE:DAR) to report earnings on February, 27. They expect $0.11 EPS, down 56.00% or $0.14 from last year’s $0.25 per share. DAR’s profit will be $18.11 million for 42.52 P/E if the $0.11 EPS becomes a reality. After $0.05 actual EPS reported by Darling Ingredients Inc. for the previous quarter, Wall Street now forecasts 120.00% EPS growth.

Southernsun Asset Management Llc increased Pentair Plc (NYSE:PNR) stake by 43,455 shares to 1.09 million valued at $73.80M in 2017Q3. It also upped Diebold Nixdorf Incorporated (NYSE:DBD) stake by 3.95M shares and now owns 6.90 million shares. Actuant Corp (NYSE:ATU) was raised too.

Among 10 analysts covering Darling Ingredients (NYSE:DAR), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Darling Ingredients had 28 analyst reports since August 12, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Sunday, August 6 by Canaccord Genuity. Robert W. Baird maintained it with “Outperform” rating and $20 target in Friday, August 11 report. The firm has “Buy” rating by BMO Capital Markets given on Friday, September 15. Robert W. Baird maintained Darling Ingredients Inc. (NYSE:DAR) rating on Friday, October 13. Robert W. Baird has “Buy” rating and $20.0 target. The stock has “Buy” rating by Roth Capital on Tuesday, October 24. Zacks downgraded the shares of DAR in report on Friday, August 21 to “Hold” rating. The firm earned “Buy” rating on Thursday, November 9 by Robert W. Baird. The company was initiated on Wednesday, October 28 by JP Morgan. The firm earned “Outperform” rating on Thursday, March 23 by Robert W. Baird. The firm earned “Hold” rating on Friday, October 6 by J.P. Morgan.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.